3303 Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naïve patients with advanced melanoma (M... by Larkin, J, Chiarion-Sileni, V, Gonzalez, R, Grob, J.J, Cowey, C.L, Lao, C.D, Wagstaff, J, Hogg, D, Hill, A, Carlino, M.S, Wolter, P, Lebbé, C, Schachter, J, Thomas, L, Hassel, J.C, Lorigan, P, Walker, D, Jiang, J, Hodi, F.S, Wolchok, J.D

Get full text

Nivolumab (NIVO) vs ipilimumab (IPI) en traitement adjuvant du mélanome de stade III/IV opéré : résultats de survie sans récidive (SSR) et de survie globale (SG) à 4 ans de l’essai... by Weber, J., Del Vecchio, M., Mandalá, M., Gogas, H., Arance, A.M., Dalle, S., Cowey, C.L., Schenker, M., Grob, J.-J., Chiarion-Sileni, V., Márquez-Rodas, I., Butler, M.O., Maio, M., Middleton, M.R., Del La Cruz-Merino, L., Lobo, M., De Pril, V., Larkin, J., Ascierto, P.A.

Get full text

Survie globale avec l’association de nivolumab (NIVO) et d’ipilimumab (IPI) dans un essai de phase III sur le mélanome avancé (CheckMate 067) by Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C.L., Lao, C.D., Schadendorf, D., Ferrucci, P.F., Smylie, M., Dummer, R., Hill, A., Haanen, J., Maio, M., McArthur, G., Lebbé, C., Dréno, B., Walker, D., Rollin, L., Horak, C., Hodi, F.S., Wolchok, J.D.

Get full text

Contrast sensitivity in rats with increased or decreased numbers of retinal ganglion cells by HEYWOOD, C. A, SILVEIRA, L. C. L, COWEY, A

Get full text